Marco Gerlinger
National Health Service · 180 works · 15,037 citations · h-index 37
Top works
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- Spatial and temporal diversity in genomic instability processes defines lung cancer evolution
- Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing
- How Darwinian models inform therapeutic failure initiated by clonal heterogeneity in cancer medicine
- Intratumor Heterogeneity: Seeing the Wood for the Trees
- Classifying the evolutionary and ecological features of neoplasms
- Cancer: Evolution Within a Lifetime
- Parallel evolution of tumour subclones mimics diversity between tumours
- Assessment of an RNA interference screen-derived mitotic and ceramide pathway metagene as a predictor of response to neoadjuvant paclitaxel for primary triple-negative breast cancer: a retrospective analysis of five clinical trials
- Cancer Evolution and the Limits of Predictability in Precision Cancer Medicine
- Genomic and Transcriptomic Determinants of Therapy Resistance and Immune Landscape Evolution during Anti-EGFR Treatment in Colorectal Cancer
- SETD2 loss-of-function promotes renal cancer branched evolution through replication stress and impaired DNA repair
- Systematic Evaluation of the Prognostic Impact and Intratumour Heterogeneity of Clear Cell Renal Cell Carcinoma Biomarkers
- Egr-1 Induces the Expression of Its Corepressor Nab2 by Activation of the Nab2 Promoter Thereby Establishing a Negative Feedback Loop
- Ultra‐deep T cell receptor sequencing reveals the complexity and intratumour heterogeneity of T cell clones in renal cell carcinomas
- P-111 PD1 and LAG3 inhibition as second+ line treatment after EGFR antibody-containing therapy in RAS/BRAF wildtype, MMRp metastatic colorectal cancer
- Intratumour Heterogeneity in Urologic Cancers: From Molecular Evidence to Clinical Implications
- Genome‐wide RNA interference analysis of renal carcinoma survival regulators identifies MCT4 as a Warburg effect metabolic target
- The Effect of VEGF-Targeted Therapy on Biomarker Expression in Sequential Tissue from Patients with Metastatic Clear Cell Renal Cancer
- Predictive biomarker discovery through the parallel integration of clinical trial and functional genomics datasets